SOURCE: Trend Exploration

January 25, 2011 16:15 ET

TRDX Reports 2010 Estimated Gross Revenues (Unaudited) to Exceed $1 Million

Revenues Anticipated to Accelerate in 2011 Based on Current Contracts

JERICHO, NY--(Marketwire - January 25, 2011) - SciMeDent Health, Corp. f/k/a Trend Exploration, Inc. (PINKSHEETS: TRDX) is pleased to announce estimated gross revenue (unaudited) for fiscal year end December 2010 will exceed $1 million. Currently, revenues for nine months ending September 2010 are $703,751 (unaudited). Year end 2010 unaudited income statement and balance sheet will immediately be released upon completion. The rise in year-end revenue was generated through TRDX's wholly owned subsidiary, Preferred Distribution, Inc., a distributor of medical, dental, health & beauty products at the lowest possible prices.

Dr. Jan Stahl, CEO of TRDX, stated, "This is an exciting time for our company. We estimate over $1 million in gross revenues for 2010, with accelerated revenue growth in 2011. Growth will be fuelled by continued contracts, increased quality products and sales. As part of our growth plans we increased our client base by becoming a distributor for Hospira, a global pharmaceutical wholesaler."

About SciMeDent f/k/a Trend Exploration, Inc. (PINKSHEETS: TRDX)

SciMeDent ( is a company focused on being a leading developer and marketer of products and services for medicine, dentistry and life sciences. SciMeDent plans to achieve growth initially through mergers and acquisitions.

About Preferred Distribution, Inc.

Preferred Distribution, Inc. is a wholly owned subsidiary of SciMeDent. Preferred's goal is to supply the medical, dental and veterinary community with quality products at the lowest possible prices. Preferred prides itself on providing professional sales staff who are courteous, knowledgeable and dedicated to saving you time and money for your practice. Since 1987 Preferred has been serving the needs of professionals throughout the country. Preferred's dental products division is marketed through its website,

About Hospira

Hospira is a global specialty pharmaceutical and medication delivery company, backed by proven leadership and more than 70 years' experience producing high-quality products. Hospira's breadth of offerings help customers address the safety, productivity and cost of patient care. Used by hospitals worldwide, Hospira products are also prevalent in outpatient clinics and other alternate healthcare sites.

Cautionary Statement Regarding Forward-Looking Statements

A number of statements contained in this press release are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the sufficiency of existing capital resources, technological or industry changes and uncertainties related to the development of the Company's business model. The actual results the Company may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.

Contact Information